This course explores the evaluation and treatment of different types of lung cancers, focusing on how systemic treatment is evolving based on molecular profiles. Students will learn about new chemotherapies, targeted drugs, gene pathways, and the rise of nonsmokers' lung cancer. The teaching method includes lectures on chemotherapy, targeted therapy, tumor markers, and clinical trials, with a strong emphasis on collaboration and community-based practice. The intended audience for this course includes healthcare professionals, oncologists, medical students, and individuals interested in the latest advancements in lung cancer care.
New Directions in Lung Cancer Care - Anita Kaul, MD - UCLA Health
University of California, Los Angeles via YouTube
Overview
Syllabus
Intro
Lung Cancer Incidence
Chemotherapy
Stage 3 Lung Cancer
New Directions in Lung Cancer
Stage 4 Lung Cancer
New chemotherapies
Avastin
Maintenance treatment
Angiogenesis switch
Antibodies
Targeted drugs
Avastin and Cetuximab
Gene pathways
Types of CAN services
ROS1 mutation
Other mutations
Alch mutation
What is a targeted drug
Lung cancer trials
Fine needle aspiration
Collaboration
Targeted Therapy
Tumor Markers
PT Skin
Communitybased practice
Clinical trials of targeted drugs
Biopsy options
Rise in nonsmokers lung cancer
Intervention for nonsmokers
Screening for lung cancer
Clinical trials for lung cancer
How are patients volunteer tumor pieces collected
Taught by
UCLA Health
